Status:
COMPLETED
mHealth Medication Safety Intervention
Lead Sponsor:
Medical University of South Carolina
Collaborating Sponsors:
Agency for Healthcare Research and Quality (AHRQ)
Conditions:
Medication Compliance
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
TRANSAFE Rx is a 12-month, parallel two-arm, 1:1 randomized controlled clinical trial, involving 136 participants (68 in each arm) measuring the clinical and economic effectiveness of a pharmacist-led...
Eligibility Criteria
Inclusion
- Kidney transplant recipient between 6 and 36 months post-transplant
- At least 18 years of age
- Transplant MD agrees that patient is eligible to participate
Exclusion
- Multi-organ recipient
- Patient is incapable of:
- Measuring their own blood pressure and glucose (if applicable)
- Self-administering medications
- Speaking, hearing and reading English
- Utilizing the mHealth application, after training
Key Trial Info
Start Date :
October 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 30 2020
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT03247322
Start Date
October 11 2017
End Date
May 30 2020
Last Update
February 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29425